119 results
Page 3 of 6
8-K
EX-99.1
i2i22lxgge06ijfefz
10 Nov 21
BioXcel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
7:15am
8-K
EX-1.1
4coreuo
25 Jun 21
Entry into a Material Definitive Agreement
5:05pm
424B5
5uc3itme4wthj i8
24 Jun 21
Prospectus supplement for primary offering
4:25pm
424B5
63gk4e lfm9ag
22 Jun 21
Prospectus supplement for primary offering
4:06pm
8-K
d8e0g5ntbwp4 xsq4
22 Jun 21
Other Events
4:04pm
8-K
EX-1.1
agy 55py5rds
10 May 21
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-99.1
k4riso
10 May 21
BioXcel Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:11am
PRE 14A
ib1k7r j21wsxzqg
14 Apr 21
Preliminary proxy
5:16pm
8-K
EX-99.1
vfgv6 t8o4k1cah1tgz
11 Mar 21
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:34am
8-K
EX-99.1
3wll has9i
12 Nov 20
BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
7:13am
8-K
EX-99.1
lu3paqmf26d6mm 7b0k
14 Aug 20
BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
7:16am
8-K
EX-1.1
atatsqyl9
31 Jul 20
Entry into a Material Definitive Agreement
5:21pm
424B5
yekz6
31 Jul 20
Prospectus supplement for primary offering
10:45am
424B5
pev7ec
27 Jul 20
Prospectus supplement for primary offering
4:36pm